Popular Articles

National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Infections
Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B. Savage of Brigham Young University, have demonstrated in a series of in vitro experiments and preclinical animal testing that an investigational drug compound known as CSA-13 shows promise as a potential therapy to treat viral infections from the vaccinia virus. The research appears ahead of print in an advanced online publication of the Journal of Investigate Dermatology, the official journal of the Society for Investigative Dermatology. This work was funded by the National Institute of Allergy and Infectious Diseases Atopic Dermatitis Vaccinia Network.
generic viagra online
Smoking Associated With More Rapid Progression Of Multiple Sclerosis
Patients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease, according to a report in the July issue of Archives of Neurology, one of the JAMA/Archives journals.
News of the day
Fungi Pathogenic To Insects Are New Tool In Fight Against Chagas Disease
Entomopathogenic fungi may be a safe and efficient means of controlling
Diagnostics

Massachusetts Could Provide Model To Pay For Reform

USA Today reports that three years after mandating coverage for all, Massachusetts is emerging as national model. Massachusetts is wrangling with the idea of changing how doctors and hospitals are paid to help finance its soaring health costs. The way they want to do so is by rewarding results. "As Washington wrestles with the idea of overhauling the nation"s health care system, the Bay State offers an object lesson in how to do it in stages. It"s an approach favored by state officials but rejected by the Obama administration, which is intent on addressing coverage, cost and quality all at once. Massachusetts dealt with coverage first: just 2.6% of state residents remain uninsured, compared with more than 15% nationally. That"s due in part to the 2006 law, which said most residents must get insurance, most employers must help provide it, and most taxpayers must help pay for it. "Dealing with cost and quality has proved trickier. Higher health care costs fueled a combined $9 billion gap in the state"s 2009 and 2010 budgets that had to be closed last month, leaving less for education, public safety, the environment and other services." Nationally, the president "seeks to extend insurance to up to 46 million people without it. At the same time, he wants to slow the growth of Medicare and Medicaid, now projected to rise from 5% of the nation"s economy to more than 17% by 2080." Some lessons to learn from Massachusetts, USA Today reports: Sell it to the public, don"t alienate interest groups and prepare for years of trial and error (Wolf, 7/23). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):